Rochdale Investment Management »

Teva Pharmaceutical Industries shares owned by Rochdale Investment Management

Quarter-by-quarter ownership of Teva Pharmaceutical Industries (TEVA) shares owned by Rochdale Investment Management from 13F filings

Historical chart of Rochdale Investment Management investment in Teva Pharmaceutical Industries

Tip: Access up to 7 years of quarterly data

All positions including Teva Pharmaceutical Industries held by Rochdale Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Teva Pharmaceutical Industries by Rochdale Investment Management

Quarter filed Position value Share count Share price at filing
2012-12-31 $329k 8.8k 37.31
2012-09-30 $399k 9.6k 41.45
2012-06-30 $380k 9.6k 39.48
2012-03-31 $492k 11k 45.03
2011-12-31 $441k 11k 40.37
2011-09-30 $407k 11k 37.25

More positions owned by Rochdale Investment Management

Verizon Communications (VZ)
Philip Morris International (PM)
At&t (T)
iShares Barclays 1-3 Year Cred Bd Fd ETF (IGSB)
Altria (MO)
Northeast Utilities System
Bristol Myers Squibb (BMY)
National Retail Properties (NNN)
Plains All American Pipeline (PAA)
Xcel Energy (XEL)
UIL Holdings Corporation
Vector (VGR)
Exxon Mobil Corporation (XOM)
Health Care REIT
B&G Foods (BGS)

View all positions for Rochdale Investment Management

Top funds holding Teva Pharmaceutical Industries

Ion Asset Management
Phoenix Holdings
Migdal Insurance & Financial Holdings
Harel Insurance Investments & Financial Services
Millennium Management
Citadel Advisors
AustralianSuper Pty
Sound Shore Management
Goldman Sachs Group
Abrams Capital Management
Soleus Capital Management
Alyeska Investment Group
Legal & General Group
Holocene Advisors
Meitav Dash Investments

View all funds holding Teva Pharmaceutical Industries